I. Caesar
Impact in
- Genetics top 5%
- Inflammatory Bowel Disease
- Gastroenterology top 10%
Papers in
- Genetics 10
- Inflammatory Bowel Disease 10
-
- Microscopic Colitis 6
- Co-authors
- Tilo Andus (13 shared papers)Jürgen Schölmerich (9 shared papers)Michael Roth (5 shared papers)Volker Groß (4 shared papers)M Gierend (5 shared papers)Frank Kullmann (1 shared paper)K. Ewe (3 shared papers)Paul Held (1 shared paper)
- Journals
- Gastroenterology (3 papers)International Journal of Colorectal Disease (1 paper)The Lancet (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)Digestive Diseases and Sciences (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
I. Caesar
16 papers receiving 557 citations
Peers
Comparison fields: 5 of 63
- Genetics 352
- Gastroenterology 45
- Epidemiology 192
- Immunology 89
- Hematology 33
Countries citing papers authored by I. Caesar
This map shows the geographic impact of I. Caesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Caesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Caesar more than expected).
Fields of papers citing papers by I. Caesar
This network shows the impact of papers produced by I. Caesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Caesar. The network helps show where I. Caesar may publish in the future.
Co-authors
The 25 scholars most cited alongside I. Caesar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 250 | |
| 2 | 1995 | 94 | |
| 3 | Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. | 1996 | 84 |
| 4 | 1993 | 29 | |
| 5 | 2004 | 25 | |
| 6 | Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis. The Factor XIII Study Group. | 1999 | 20 |
| 7 | 1996 | 19 | |
| 8 | Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group. | 1997 | 18 |
| 9 | Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group. | 1995 | 11 |
| 10 | 1998 | 8 | |
| 11 | 1998 | 8 | |
| 12 | 1997 | 2 | |
| 13 | [Transitory increase of the thyroid stimulating hormone in the newborn after polyvinylpyrrolidon-iodine application during parturition (author's transl)]. | 1979 | 2 |
| 14 | 1998 | 2 | |
| 15 | 1998 | 1 | |
| 16 | 1995 | 1 |
About I. Caesar
I. Caesar is a scholar working on Genetics, Epidemiology, Surgery, Gastroenterology and Pathology and Forensic Medicine, having authored 16 papers that have together received 574 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (6 papers), Celiac Disease Research and Management (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Pregnancy and Medication Impact (1 paper), Liver Diseases and Immunity (1 paper), Blood properties and coagulation (1 paper) and Thyroid Disorders and Treatments (1 paper). The work is most often cited by research in Genetics (352 citations), Gastroenterology (45 citations), Epidemiology (192 citations), Immunology (89 citations) and Hematology (33 citations). I. Caesar has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Tilo Andus, Jürgen Schölmerich, Michael Roth, Volker Groß, M Gierend, Frank Kullmann, K. Ewe, Paul Held, Audrey Weber and Stefan Feuerbach. Their work appears in journals such as Gastroenterology, International Journal of Colorectal Disease, The Lancet, European Journal of Gastroenterology & Hepatology and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.